carnitine has been researched along with Cytomegalic Inclusion Disease in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Adefovir dipivoxil is a novel nucleotide analogue with several promising in vitro anti-human immunodeficiency virus (HIV) characteristics." | 2.68 | The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. ( Cherrington, JM; Collier, A; Deeks, SG; Drew, WL; Hellmann, N; Jaffe, HS; Kahn, J; Lalezari, J; Lamy, PD; Li, W; Mulato, AS; Pavia, A; Rodrigue, D; Toole, J, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deeks, SG | 1 |
Collier, A | 1 |
Lalezari, J | 1 |
Pavia, A | 1 |
Rodrigue, D | 1 |
Drew, WL | 1 |
Toole, J | 1 |
Jaffe, HS | 1 |
Mulato, AS | 1 |
Lamy, PD | 1 |
Li, W | 1 |
Cherrington, JM | 1 |
Hellmann, N | 1 |
Kahn, J | 1 |
1 trial available for carnitine and Cytomegalic Inclusion Disease
Article | Year |
---|---|
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.
Topics: Adenine; Administration, Oral; Adult; Anti-HIV Agents; Carnitine; CD4 Lymphocyte Count; Cytomegalovi | 1997 |